Objective: HIV-1 persists indefinitely in memory CD4 þ T cells and other long-lived cellular reservoirs despite antiretroviral therapy. Our group had previously demonstrated that HIV-1 can establish a productive infection in renal epithelial cells and that the kidney represents a separate compartment for HIV-1 replication. Here, to better understand the viruses in this unique site, we genetically characterized and compared the viruses in blood and urine specimens from 24 HIV-1 infected patients with detectable viremia.
Introduction
HIV-1 can infect and persist in different organs and tissues. The infection of different cell types results in the generation of distinct viral populations that replicate within their unique environments and are subject to diverse selective pressure [1] . Some organs can maintain distinct viral compartments that can persist and serve as reservoirs for HIV-1 despite antiretroviral therapy (ART) [2] . Compartments, defined as anatomic environments, restrict HIV-1 trafficking and gene flow, favor viral evolution and divergence from the viral population in the peripheral blood [3] . HIV-1 compartmentalization has been documented in the central nervous system (CNS), lymph nodes, breast milk, and genital tract [4] [5] [6] . Understanding HIV-1 dynamics in different compartments and reservoirs is crucial for designing effective strategies to cure infected individuals. In our previous studies, we have shown that HIV-1 infects renal epithelial cells in vitro and in vivo and that the kidney represents a separate compartment for HIV-1 replication in patients with HIV-associated nephropathy (HIVAN) [7] [8] [9] . In a recent examination of renal biopsies from ARTsuppressed HIV-positive patients undergoing kidney transplantation, HIV-1 was detected in graft renal tubular cells and/or podocytes in 68% of patients despite the absence of detectable plasma viremia [10] , underscoring the importance of renal epithelial cells as a unique target for HIV-1. Understanding the long-term consequences of this nonhematologic reservoir is challenging as renal biopsies pose a risk to patients and repeated biopsies are rarely performed. We therefore amplified and characterized HIV-1 env sequences in urine specimens from HIV-1 positive patients with normal kidney function (non-HIVAN), to determine if viruses in urine represent a separate compartment that might reflect the renal reservoir.
Materials and methods
Study participants and samples processing Blood and overnight urine samples were obtained from 35 HIV-1-positive patients. All participants gave informed consent, and sample collections were performed with institutional review board's approval (Pro00008576). Large volumes of urine ranging from 35 to 630 ml (Supplementary Table 1 , http://links.lww.com/QAD/A719) were collected overnight in 100 ml urine containers and kept at 48C until processed the following morning. EDTA anticoagulated blood samples were processed within 2 h from collection to isolate plasma and peripheral blood mononuclear cell (PBMC) by Ficoll gradient centrifugation. Urine samples were spun at 1500 rpm for 10 min to separate urine supernatants from urinary cells. Supernatants were then filtered through a 0.45 mm filter unit to remove cellular debris followed by 2 h of ultracentrifugation to pellet HIV virions. Pelleted viruses were then resuspended in 400 ml of 1X phosphate-buffered saline and either immediately subjected to RNA extraction or stored at À808C. Urinary cell pellets were stored at À208C until DNA extraction.
Viral RNA extraction and cDNA synthesis Viral RNA was extracted from 400 ml of concentrated urine or plasma by using the EZ1 virus Mini Kit v2.0 (Qiagen, Venlo, Netherlands). RNA was eluted in a final volume of 60 ml, 20 ml of which were immediately subjected to cDNA synthesis. Reverse transcription of RNA to single-stranded cDNA was performed with Super-Script III reverse transcriptase following manufacturer's instructions (Invitrogen Life Technologies, Grand Island, New York, USA). Briefly, each cDNA reaction included 1X reverse transcription buffer, 0.5 mmol each deoxynucleoside triphosphate, 5 mmol dithiothreitol, 2 units/ml RNaseOUT (RNase inhibitor; Invitrogen Life Technologies), 10 units/ml Super-Script III reverse transcriptase, and 0.25 mmol/l antisense primer 1.R3.B3R 5'-ACTACTTGAAGCACTCAAGGCAAGCTTTATT G-3'. The mixture was incubated at 508C for 60 min, followed by an increase in temperature to 558C for an additional 60 min. The reaction was then heat-inactivated at 708C for 15 min and then treated with RNaseH at 378C for 20 min. The newly synthesized cDNA was used immediately or kept frozen at À808C.
Viral DNA extraction
Viral DNA was extracted from 5 Â 10 6 PBMC by using the QIAamp mini kit and from the urine cell pellet by using the QIAamp micro kit (Qiagen) following the manufacturer's instructions, and eluted in 50 ml of water.
Single-genome amplification cDNA was serially diluted and 1 ml of each dilution was distributed among wells of replicate 96-well plates so as to identify a dilution wherein PCR-positive wells constituted less than 30% of the total number of reactions. At this dilution, most positive wells contain amplicons derived from a single cDNA molecule. This was confirmed in every positive reaction by direct sequencing of the amplicon and inspection of the sequence for double peaks, which would be evidence of priming from more than one original template or the introduction of PCR errors in early cycles. Any sequence with evidence of mixed bases was excluded from further analysis. Firstround PCR primers included sense primer Env5out 5'-T AGAGCCCTGGAAGCATCCAGGAAG-3' and antisense primer Env3out 5'-TTGCTACTTGTGATTGC TCCATGT-3', which generated a approximately 3-kb product. PCR was performed in 96-well PCR reaction plates with the following PCR parameters: 1 cycle of 948C for 2 min; 35 cycles of a denaturing step of 948C for 15 s, an annealing step of 558C for 30 s, an extension step of 688C for 4 min, followed by a final extension of 688C for 10 min. Two ml from first-round PCR product were added to a second-round PCR that included the sense primer Env5in 5'-CACCTTAGGCATCTCCTATG GCAGGAAGAAG-3' and antisense primer Env3in 5'-GTCTCGAGATACTGCTCCCACCC-3'. The second-round PCR was carried out under the same conditions used for first-round PCR but for a total of 45 cycles. Amplicons were separated on 1% agarose gels and positive bands were excised from the gel and PCR products were purified using the QIAquick gel extraction kit (Qiagen). All PCR procedures were carried out under PCR clean room conditions with procedural safeguards against sample contamination. Amplifications were performed using the Eppendorf Mastercycler pro (Eppendorf, Hamburg, Germany).
Sequencing and sequence alignments
The env gene amplicons were sequenced by using the primer walking method. Individual sequence fragments for each amplicon were assembled and edited by using the Sequencher program 5.0 (Gene Codes Corporation, Ann Arbor, Michigan, USA). Inspection of individual chromatograms allowed for the identification of amplicons derived from single versus multiple templates. The absence of mixed bases at each nucleotide position throughout the entire env gene was taken as evidence of amplification from a single viral RNA/cDNA template. All alignments and phylogenetic trees were made with MEGA6 [25] . Neighbor-joining trees were constructed under the Kimura 2-parameter model and the reliability of topologies was estimated by performing bootstrap analysis with 1000 replicates.
Statistics
Nonparametric Spearman's correlation analysis between number of urinary sequences and plasma viral load was performed using Graph-Pad Prism 6.0 software (GraphPad Software, Inc., San Diego, California, USA).
Results
Fifty percent of viremic HIV-1-positive patients have viral RNA in their urine Blood and urine specimens were simultaneously collected from a total of 35 HIV-1 positive patients (Supplementary Table 1 , http://links.lww.com/QAD/A719), 24 with detectable viremia and 11 with undetectable viral load. We performed single-genome amplification [11, 12] on HIV-1 env RNA and DNA isolated from urine supernatants and urine-derived cell pellets, respectively, as well as from plasma and PBMC from the same individuals. We were able to amplify the full-length HIV-1 env gene in urine supernatants from 12 of the 24 viremic patients analyzed in this study and obtained multiple env sequences from the majority of them (Table 1 and Supplementary Figure 1 , http://links.lww.com/QAD/ A719). On the contrary, no envelope sequence could be derived from urine samples in the 11 suppressed patients, suggesting that ART is effective in suppressing viral replication in the urine compartment.
HIV-1 variants in urine are compartmentalized from the viral population in blood and clonally amplified To determine whether the viral population in the urine is different from the viruses in the blood, we performed phylogenetic tree analysis of sequences obtained from four of the patients from which we were able to amplify multiple HIV-1 env sequences (>15). As shown in Fig. 1 (a-c) , the majority of the urine-derived env sequences form independent clusters among the PBMC and plasmaderived sequences, suggesting that viruses found in the urine were generated from a separate compartment in the genitourinary tract. In the one male patient (patient 290), the lower genital tract (i.e. seminal tract) could have contributed to the urine sequences. However, the presence of urine-derived sequence in the three female patients precludes the male lower genitourinary tract as the only source of virus in the urine. We observed a higher frequency of identical or nearly identical sequences in urine than in blood. Because of the nature of the single genome amplification approach, this cannot be the result of PCR resampling, as each amplicon was generated from a single template, therefore it suggests clonal amplification of virus in this compartment. To assess whether viruses derived from the urinary compartment had a different coreceptor tropism from plasma viruses, we determined coreceptor usage of viruses by using the Geno2pheno [coreceptor] algorithm with a 10% false-positive rate [13] . No difference in coreceptor usage was observed between blood and urine-derived sequences.
Amplification of HIV-1 DNA from cells shed in urine
Although we did not have simultaneous renal biopsies from the participants enrolled in this study to allow a comparison between HIV-1 DNA in the kidney with the virus RNA found in the urine, we amplified HIV-1 env DNA sequences from epithelial cells shed in the urine. As expected, the number of cells found in the urine was variable among the different participants and often very low. Nevertheless, in three of the 12 patients positive for HIV RNA in the urine, we were able to amplify and sequence HIV-1 env DNA from the urine-derived cell pellet ( Supplementary Figure 1 , http://links.lww.com/ QAD/A719). In Fig. 2 , the phylogenetic tree for one of the three patients from which we amplified a total of five HIV-1 env sequences from the urine-derived cell pellet is shown. Interestingly, we found evidence of coclustering of some of these sequences with some of the urine RNA sequences, whereas other sequences are interspersed among the PBMC and plasma-derived sequences. We observed contaminating blood cells in the urine cell pellet from this patient, which could explain the presence of more urine/blood intermixed sequences in this patient compared with the others. These data suggest that, as it has been described for semen [14] , the virus in urine can arise through multiple mechanisms: direct import from blood, which results in equilibrated viral populations between urine and blood, as observed in patient 280; autonomous viral replication in the genitourinary tract, which results in compartmentalization; and clonal amplification of virus in this compartments, as observed in the other three patients.
Discussion
Our study represents the first genetic characterization of HIV-1 RNA and DNA in urine. We found viral RNA in the urine of 50% of viremic HIV-1-positive patients and sequence analysis showed features characteristic of viral compartmentalization distinct from blood. We also showed that in patients with undetectable plasma viral load, viral RNA is also undetectable in urine, suggesting that ART is effective in suppressing viral replication in the urine compartment. Interestingly, we found that plasma viral load does not strictly correlate with the number of distinct viral sequences derived from urine (Spearman's r, 0.3759; P ¼ 0.0703; Supplementary  Figure 2 267 (4460 copies/ml), we amplified more than 15 HIV-1 env sequences from a volume of urine as low as 35 ml, whereas in other patients with very high viral load (>1 million copies/ml), none or only few sequences were derived from a large volume of urine (Supplementary Table 1 , http://links.lww.com/QAD/A719). We collected high volumes of urine from the majority of the patients enrolled in this study in order to increase the chances of amplifying HIV-1 RNA, but interestingly multiple HIV-1 env sequences were derived from as low as 8 ml of urine. These data suggest that the dynamics of virus release in the urine is independent from virus production in the blood and is more likely dependent on the number of cells infected in this separate compartment. Interestingly, in our previously reported in-situ hybridization study, we found that approximately 50% of patients had detectable viral RNA and/or DNA in their renal biopsies [26] . It is also possible that, as it has been observed in semen [15, 16] , HIV-1 shedding in urine may be intermittent leading to the absence of virus in some samples. Future studies will address this question by analyzing follow-up urine specimens. Notably, in many instances, we amplified a certain number of identical env sequences from the same patient in independent PCR reactions. Identical sequences have been previously isolated from plasma of patients both chronically infected [17, 18] or under suppressive ART and were found to be distinct from most of the viruses found in resting CD4 þ T cells or activated CD4 þ T cells in the circulation, suggesting that those similar viruses come from a different source [19] . Furthermore, in a recent study by Maldarelli et al. [20] , identical sequences isolated from patients on ART were present also before therapy initiation and were shown to be the result of clonal expansion of infected cells in which HIV-1 had integrated in genes that regulate cell growth and division. These data were confirmed by Wagner et al. [21] , and suggest that clonal expansion of infected cells can contribute to HIV persistence [20] . Interestingly, three recent publications independently showed that individual renal epithelial cells mediate tubulogenesis and renal epithelial repair during acute renal injury with single cell clones that contribute to segmental tubular regeneration [22] [23] [24] . In the setting of HIV-1 infection of renal epithelial cells, it is possible that clones of infected renal tubule epithelial cells undergo cell division in an attempt to repair the injured renal tubule giving rise to clonal expansion of HIV-1-infected cells in the tubules. Our previous observation of the unique pattern of HIV-1 infection of renal tubules in HIVAN biopsies, in which the majority of cells lining a renal tubule were infected [26] , supports this hypothesis or alternatively cell-to-cell transfer of HIV and further provides a possible explanation for the presence of identical sequences in the urine. In a previous study by Li et al. [27] , HIV-1 DNA and RNA were detected in a small number of urinary cells in 66% of HIV-1 positive patients. Although in these samples we were able to obtain cell-associated HIV-1 env sequences from the limited urine cells, these data suggest that increasing the number of renal epithelial cells in the urine, as might be found in HIV-1 positive patients with acute tubular necrosis, will provide a more definitive comparison between HIV-1 viral RNA and cell associated DNA in the urine. This would also allow determination of preferential integration sites in the genome of urine epithelial cells. In male patients, it is possible that viruses produced in the lower genital tract could be present in urine specimens. In the present study, three of the four patients for which separate phylogenetic trees are shown are women, precluding the male lower genitourinary tract as the only source of virus in the urine. In conclusion, our study demonstrates that the amplification and analysis of urinederived HIV-1 sequences is a feasible noninvasive approach and allows analysis of a unique genitourinary compartment that could serve as a nonblood viral reservoir to be studied in developing broader strategies to cure HIV-1.
